Global TB Summit 2024: QIAGEN’s QuantiFERON®-TB Gold Plus Blood Test at the Forefront of Latent TB Detection and Global Disease Control

QIAGEN’s leading tuberculosis blood test QuantiFERON®-TB Gold Plus remains crucial for detection of latent tuberculosis infection, aiding in ...

October 08, 2024 | Tuesday | News
Citryll Launches Pioneering Collaboration with Dutch Rheumatology Experts to Advance NET-Targeting Therapies for Rheumatoid Arthritis

Learnings will be used in the clinical development programs of NET-targeting therapies such as Citryll’s lead anti-inflammatory candidate CIT-013 ...

October 03, 2024 | Thursday | News
LeaderMed and Combiphar Form Joint Venture to Launch Phase 3 Trial of Novel Diabetes Treatment in Indonesia

LeaderMed Group (LeaderMed), a global pharmaceutical development company, and Combiphar, a leading Indonesian pharmaceutical company in Southeast Asia, ann...

October 01, 2024 | Tuesday | News
Thermo Fisher Scientific Launches Global Adolescent Atopic Dermatitis Registry to Advance Treatment Research

Thermo Fisher Scientific Inc., the world leader in serving science, announced the launch of the international CorEvitas Adolescent Atopic Dermatitis (AD)...

October 01, 2024 | Tuesday | News
SIFI Secures European Patent for Innovative Polihexanide Formulation in Germany Eye Infection Treatment

The company's intellectual property ("IP") covers the formulation and method of use of polihexanide in the treatment of acanthamoeba keratitis and fung...

September 30, 2024 | Monday | News
Enliven Therapeutics Reports Promising 44% MMR Rate at 24 Weeks in Phase 1 CML Trial for ELVN-001

Reported cumulative MMR rate of 44% by 24 weeks, with stable or deepening responses between weeks 12 and 24, continuing to surpass prior Phase 1 trials o...

September 30, 2024 | Monday | News
Takara Bio Europe Launches Shasta™ Single-Cell System, Advancing High-Throughput Oncology Biomarker Discovery

Takara Bio Europe, a wholly owned subsidiary of Takara Bio Inc., announces the launch of the Shasta™ Single-Cell System at the 2024 Human Cell A...

September 27, 2024 | Friday | News
Telesis Bio and Beckman Coulter Life Sciences Partner to Create Scalable Biofoundries for Rapid, High-Fidelity DNA Synthesis

A new partnership between Telesis Bio and Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, will create efficient a...

September 26, 2024 | Thursday | News
Metabolomics Diagnostics Develops PrePsia, an Innovative Test to Predict Preeclampsia Risk in Early Pregnancy

-Metabolomics Diagnostics, a deep-tech machine learning diagnostic platform developer, has developed an innovative test, PrePsia, to accurately predict t...

September 25, 2024 | Wednesday | News
Roche Launches cobas® Respiratory flex Test, Powered by Innovative TAGS Technology

New TAGS (Temperature-Activated Generation of Signal) technology enables up to 15 targets to be detected simultaneously in a single patient sample on t...

September 24, 2024 | Tuesday | News
AbbVie’s Mirvetuximab Soravtansine Receives Positive CHMP Recommendation for Platinum-Resistant Ovarian Cancer Treatment in EU

AbbVie announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommen...

September 23, 2024 | Monday | News
Novo Nordisk’s Wegovy® Receives Positive Opinion from EMA for Label Update Reflecting Reduced Heart Failure Symptoms

Novo Nordisk announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opin...

September 20, 2024 | Friday | News
Vidac Pharma Secures Broad U.S. Patent for Pioneering Cancer Treatment Mode of Action

Vidac Pharma Holdings Plc., a clinical-stage oncology biopharmaceutical company pioneering a novel class of cancer treatments,  announces that the U...

September 19, 2024 | Thursday | News
Roche's Xofluza Shows Single-Dose Can Reduce Influenza Transmission in Landmark Global Study

Data from the CENTERSTONE study shows single-dose Xofluza reduces transmission of influenza from an infected person to household members This is the f...

September 19, 2024 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close